🚀
Enjoy a 7-Day Free Trial Thru Apr 24, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Zymeworks Inc (NAS:ZYME)
News
Zymeworks Inc - Registered Shs
1
4
NAS
:ZYME (USA) Â
Registered Shs
$ 8.93
-0.16 (-1.76%)
10:08 PM EST
P/E:
At Loss
P/B:
1.35
Market Cap:
$ 630.17M
Enterprise V:
$ 293.86M
Volume:
263.49K
Avg Vol (2M):
563.63K
Warning! GuruFocus detected 4 Severe warning signs with ZYME.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
263.49K
Market Cap $:
630.17M
PE Ratio:
At Loss
Avg Vol (2M):
563.63K
Enterprise Value $:
293.86M
PB Ratio:
1.35
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Zymeworks Inc (NAS:ZYME) Stock News, Headlines & Updates
Zymeworks Inc Stock News from GuruFocus
Total 67
1
2
Apr 16, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEÂ
Marketwired
•
3:00pm
Apr 12, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PRNewswire
•
9:00am
Apr 11, 2024
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
Marketwired
•
5:00am
Apr 04, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PRNewswire
•
6:00pm
Mar 08, 2024
Zymeworks Inc at Citi Virtual Oncology Leadership Summit Transcript
GuruFocus Research
•
11:46am
Mar 07, 2024
Zymeworks Inc (ZYME) Reports Financial Results for Q4 and Full Year 2023
GuruFocus Research
•
12:28pm
Q4 2023 Zymeworks Inc Earnings Call Transcript
GuruFocus Research
•
11:03pm
Feb 09, 2024
Zymeworks Inc at JPMorgan Healthcare Conference Transcript
GuruFocus Research
•
1:51pm
Q3 2023 Zymeworks Inc Earnings Call Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc at Citi BioPharma Conference Transcript
GuruFocus Research
•
1:51pm
Q2 2023 Zymeworks Inc Earnings Call Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc at Bank of America Global Healthcare Conference Transcript
GuruFocus Research
•
1:51pm
Q1 2023 Zymeworks Inc Earnings Call Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc Investor Call Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc at Barclays Global Healthcare Conference Transcript
GuruFocus Research
•
1:51pm
Q4 2022 Zymeworks Inc Earnings Call Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc at JPMorgan Healthcare Conference Transcript
GuruFocus Research
•
1:51pm
Zymeworks Inc HERIZON-BTC-01 Top-Line Results Call Transcript
GuruFocus Research
•
1:51pm
Jan 10, 2024
Zymeworks Inc CEO Kenneth Galbraith Sells 23,904 Shares
GuruFocus Research
•
7:35pm
Jan 09, 2024
Zymeworks Inc Chief Scientific Officer Paul Moore Sells 9,799 Shares
GuruFocus Research
•
6:44pm
Nov 01, 2023
Zymeworks Announces Participation in Upcoming Investor Conferences
Marketwired
•
8:00am
Oct 17, 2023
Zymeworks To Host Third Quarter 2023 Results Conference Call
Marketwired
•
8:00am
Oct 16, 2023
Zymeworks Announces New Director Nominee
Marketwired
•
4:00pm
Aug 10, 2023
Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Marketwired
•
4:00pm
Aug 01, 2023
Zymeworks Announces Participation in Upcoming Investor Conferences
Marketwired
•
8:00am
Jul 19, 2023
Zymeworks To Host Second Quarter 2023 Results Conference Call
Marketwired
•
8:00am
Jul 03, 2023
Zymeworks Announces Participation in Upcoming Investor Conference
Marketwired
•
8:00am
Jun 29, 2023
Zymeworks Appoints New Director
Marketwired
•
4:00pm
Jun 26, 2023
Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
Marketwired
•
8:00am
Dec 15, 2022
Insider Alert: An Insider Just Sold Zymeworks BC Inc Shares
GuruFocus Research
•
12:30pm
Jul 17, 2021
Zymeworks Inc (ZYME) CEO Ali Tehrani Sold $1.6 million of Shares
GuruFocus Research
•
11:15am
Jul 08, 2021
Zymeworks to Present at Ladenburg Thalmann Healthcare Conference
Business Wire
•
8:04am
Jun 25, 2021
Cormorant Asset Management, LLC Buys Design Therapeutics Inc, Edgewise Therapeutics Inc, Tarsus Pharmaceuticals Inc, Sells Beam Therapeutics Inc, Immunovant Inc,
GuruFocus Research
•
11:38pm
May 26, 2021
Zymeworks to Present at Jefferies Virtual Healthcare Conference
Business Wire
•
8:01am
May 17, 2021
Zymeworks Stock Appears To Be Significantly Overvalued
GF Value
•
12:12am
May 05, 2021
Zymeworks Reports 2021 First Quarter Financial Results
Business Wire
•
4:01pm
Apr 19, 2021
Zymeworks Announces Succession Plan for Chief Medical Officer
Business Wire
•
8:00am
Mar 30, 2021
Zymeworks Stock Appears To Be Significantly Overvalued
GF Value
•
3:12pm
Mar 11, 2021
Zymeworks Announces Five Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
Business Wire
•
7:00pm
Total 67
1
2
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news